These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14977859)

  • 1. Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness.
    Boyd DD; Wang H; Avila H; Parikh NU; Kessler H; Magdolen V; Gallick GE
    Clin Cancer Res; 2004 Feb; 10(4):1545-55. PubMed ID: 14977859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
    Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
    Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells.
    Wang H; Yang L; Jamaluddin MS; Boyd DD
    J Biol Chem; 2004 May; 279(21):22674-83. PubMed ID: 15031282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1.
    Allgayer H; Wang H; Gallick GE; Crabtree A; Mazar A; Jones T; Kraker AJ; Boyd DD
    J Biol Chem; 1999 Jun; 274(26):18428-37. PubMed ID: 10373450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
    Johnson FM; Saigal B; Talpaz M; Donato NJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system.
    Fibbi G; Pucci M; D'Alessio S; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
    Growth Factors; 2001; 19(2):87-100. PubMed ID: 11769974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells.
    Bartscht T; Lehnert H; Gieseler F; Ungefroren H
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):221-30. PubMed ID: 22699812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynolds LM
    J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
    Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
    Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
    Paciucci R; Torà M; Díaz VM; Real FX
    Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
    Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
    Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
    Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
    Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
    Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
    Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
    Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
    Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.